Arcadia Biosciences Announces Board and Executive Compensation Changes
Ticker: RKDA · Form: 8-K · Filed: Aug 29, 2025 · CIK: 1469443
| Field | Detail |
|---|---|
| Company | Arcadia Biosciences, Inc. (RKDA) |
| Form Type | 8-K |
| Filed Date | Aug 29, 2025 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation, governance
Related Tickers: RKDA
TL;DR
Arcadia Biosciences (RKDA) is shuffling its board and executive pay structure.
AI Summary
Arcadia Biosciences, Inc. announced on August 26, 2025, changes related to its board of directors and executive compensation. The filing details the departure of directors, election of new directors, and adjustments to compensatory arrangements for certain officers. Specific names of departing and newly elected directors, as well as details of compensation changes, are provided within the document.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, and future performance expectations.
Risk Assessment
Risk Level: medium — Changes in board and executive compensation can indicate internal shifts that may impact future strategy and performance.
Key Players & Entities
- Arcadia Biosciences, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- August 26, 2025 (date) — Date of earliest event reported
FAQ
What specific changes were made to the board of directors?
The filing indicates the departure of directors and the election of new directors, with specific details to be found within the document's sections on director changes.
Are there any changes to executive compensation arrangements?
Yes, the filing explicitly mentions 'Compensatory Arrangements of Certain Officers,' indicating adjustments or new arrangements are detailed.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on August 26, 2025.
What is Arcadia Biosciences, Inc.'s principal executive office address?
The principal executive offices are located at 5950 Sherry Lane Suite 215, Dallas, Texas, 75225.
What is the company's SIC code and what industry does it represent?
The company's SIC code is 1311, which corresponds to Crude Petroleum & Natural Gas.
Filing Stats: 1,540 words · 6 min read · ~5 pages · Grade level 15 · Accepted 2025-08-29 17:04:22
Filing Documents
- rkda-20250826.htm (8-K) — 55KB
- 0000950170-25-112267.txt ( ) — 161KB
- rkda-20250826.xsd (EX-101.SCH) — 24KB
- rkda-20250826_htm.xml (XML) — 5KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ARCADIA BIOSCIENCES, INC. Date: August 29, 2025 By: /s/ THOMAS J. SCHAEFER Thomas J. Schaefer, Chief Executive Officer